Correction to: Risk-adapted therapy and biological heterogeneity in pineoblastoma: integrated clinico-pathological analysis from the prospective, multi-center SJMB03 and SJYC07 trials (Acta Neuropathologica, (2020), 139, 2, (259-271), 10.1007/s00401-019-02106-9)

Anthony P.Y. Liu; Brian Gudenas; Tong Lin; Brent A. Orr; Paul Klimo; Rahul Kumar; Eric Bouffet; Sridharan Gururangan; John R. Crawford; Stewart J. Kellie; Murali Chintagumpala; Michael J. Fisher; Daniel C. Bowers; Tim Hassall; Daniel J. Indelicato; Arzu Onar-Thomas; David W. Ellison; Frederick A. Boop; Thomas E. Merchant; Giles W. Robinson; Paul A. Northcott; Amar Gajjar

doi:10.1007/s00401-019-02115-8

Correction to: Risk-adapted therapy and biological heterogeneity in pineoblastoma: integrated clinico-pathological analysis from the prospective, multi-center SJMB03 and SJYC07 trials (Acta Neuropathologica, (2020), 139, 2, (259-271), 10.1007/s00401-019-02106-9)

Anthony P.Y. Liu, Brian Gudenas, Tong Lin, Brent A. Orr, Paul Klimo, Rahul Kumar, Eric Bouffet, Sridharan Gururangan, John R. Crawford, Stewart J. Kellie, Murali Chintagumpala, Michael J. Fisher, Daniel C. Bowers, Tim Hassall, Daniel J. Indelicato, Arzu Onar-Thomas, David W. Ellison, Frederick A. Boop, Thomas E. Merchant, Giles W. RobinsonPaul A. Northcott, Amar Gajjar

Research output: Contribution to journal › Comment/debate › peer-review

3 Scopus citations

Abstract

The original version of this article unfortunately contained a typesetting error in Fig 3c. The corrected Fig. 3 is given in the following page (Figure presented.).

Original language	English (US)
Pages (from-to)	273-275
Number of pages	3
Journal	Acta Neuropathologica
Volume	139
Issue number	2
DOIs	https://doi.org/10.1007/s00401-019-02115-8
State	Published - Feb 1 2020

ASJC Scopus subject areas

Pathology and Forensic Medicine
Clinical Neurology
Cellular and Molecular Neuroscience

Access to Document

10.1007/s00401-019-02115-8

Fingerprint

Dive into the research topics of 'Correction to: Risk-adapted therapy and biological heterogeneity in pineoblastoma: integrated clinico-pathological analysis from the prospective, multi-center SJMB03 and SJYC07 trials (Acta Neuropathologica, (2020), 139, 2, (259-271), 10.1007/s00401-019-02106-9)'. Together they form a unique fingerprint.

Cite this

Liu, A. P. Y., Gudenas, B., Lin, T., Orr, B. A., Klimo, P., Kumar, R., Bouffet, E., Gururangan, S., Crawford, J. R., Kellie, S. J., Chintagumpala, M., Fisher, M. J., Bowers, D. C., Hassall, T., Indelicato, D. J., Onar-Thomas, A., Ellison, D. W., Boop, F. A., Merchant, T. E., ... Gajjar, A. (2020). Correction to: Risk-adapted therapy and biological heterogeneity in pineoblastoma: integrated clinico-pathological analysis from the prospective, multi-center SJMB03 and SJYC07 trials (Acta Neuropathologica, (2020), 139, 2, (259-271), 10.1007/s00401-019-02106-9). Acta Neuropathologica, 139(2), 273-275. https://doi.org/10.1007/s00401-019-02115-8

Correction to: Risk-adapted therapy and biological heterogeneity in pineoblastoma: integrated clinico-pathological analysis from the prospective, multi-center SJMB03 and SJYC07 trials (Acta Neuropathologica, (2020), 139, 2, (259-271), 10.1007/s00401-019-02106-9). / Liu, Anthony P.Y.; Gudenas, Brian; Lin, Tong et al.
In: Acta Neuropathologica, Vol. 139, No. 2, 01.02.2020, p. 273-275.

Research output: Contribution to journal › Comment/debate › peer-review

Liu, APY, Gudenas, B, Lin, T, Orr, BA, Klimo, P, Kumar, R, Bouffet, E, Gururangan, S, Crawford, JR, Kellie, SJ, Chintagumpala, M, Fisher, MJ, Bowers, DC, Hassall, T, Indelicato, DJ, Onar-Thomas, A, Ellison, DW, Boop, FA, Merchant, TE, Robinson, GW, Northcott, PA & Gajjar, A 2020, 'Correction to: Risk-adapted therapy and biological heterogeneity in pineoblastoma: integrated clinico-pathological analysis from the prospective, multi-center SJMB03 and SJYC07 trials (Acta Neuropathologica, (2020), 139, 2, (259-271), 10.1007/s00401-019-02106-9)', Acta Neuropathologica, vol. 139, no. 2, pp. 273-275. https://doi.org/10.1007/s00401-019-02115-8

Liu APY, Gudenas B, Lin T, Orr BA, Klimo P, Kumar R et al. Correction to: Risk-adapted therapy and biological heterogeneity in pineoblastoma: integrated clinico-pathological analysis from the prospective, multi-center SJMB03 and SJYC07 trials (Acta Neuropathologica, (2020), 139, 2, (259-271), 10.1007/s00401-019-02106-9). Acta Neuropathologica. 2020 Feb 1;139(2):273-275. doi: 10.1007/s00401-019-02115-8

Liu, Anthony P.Y. ; Gudenas, Brian ; Lin, Tong et al. / Correction to : Risk-adapted therapy and biological heterogeneity in pineoblastoma: integrated clinico-pathological analysis from the prospective, multi-center SJMB03 and SJYC07 trials (Acta Neuropathologica, (2020), 139, 2, (259-271), 10.1007/s00401-019-02106-9). In: Acta Neuropathologica. 2020 ; Vol. 139, No. 2. pp. 273-275.

@article{ded5869c8a054036bf438c4c4850f8a5,

title = "Correction to: Risk-adapted therapy and biological heterogeneity in pineoblastoma: integrated clinico-pathological analysis from the prospective, multi-center SJMB03 and SJYC07 trials (Acta Neuropathologica, (2020), 139, 2, (259-271), 10.1007/s00401-019-02106-9)",

abstract = "The original version of this article unfortunately contained a typesetting error in Fig 3c. The corrected Fig. 3 is given in the following page (Figure presented.).",

author = "Liu, {Anthony P.Y.} and Brian Gudenas and Tong Lin and Orr, {Brent A.} and Paul Klimo and Rahul Kumar and Eric Bouffet and Sridharan Gururangan and Crawford, {John R.} and Kellie, {Stewart J.} and Murali Chintagumpala and Fisher, {Michael J.} and Bowers, {Daniel C.} and Tim Hassall and Indelicato, {Daniel J.} and Arzu Onar-Thomas and Ellison, {David W.} and Boop, {Frederick A.} and Merchant, {Thomas E.} and Robinson, {Giles W.} and Northcott, {Paul A.} and Amar Gajjar",

note = "Publisher Copyright: {\textcopyright} 2019, Springer-Verlag GmbH Germany, part of Springer Nature.",

year = "2020",

month = feb,

day = "1",

doi = "10.1007/s00401-019-02115-8",

language = "English (US)",

volume = "139",

pages = "273--275",

journal = "Acta Neuropathologica",

issn = "0001-6322",

publisher = "Springer Verlag",

number = "2",

}

TY - JOUR

T1 - Correction to

T2 - Risk-adapted therapy and biological heterogeneity in pineoblastoma: integrated clinico-pathological analysis from the prospective, multi-center SJMB03 and SJYC07 trials (Acta Neuropathologica, (2020), 139, 2, (259-271), 10.1007/s00401-019-02106-9)

AU - Liu, Anthony P.Y.

AU - Gudenas, Brian

AU - Lin, Tong

AU - Orr, Brent A.

AU - Klimo, Paul

AU - Kumar, Rahul

AU - Bouffet, Eric

AU - Gururangan, Sridharan

AU - Crawford, John R.

AU - Kellie, Stewart J.

AU - Chintagumpala, Murali

AU - Fisher, Michael J.

AU - Bowers, Daniel C.

AU - Hassall, Tim

AU - Indelicato, Daniel J.

AU - Onar-Thomas, Arzu

AU - Ellison, David W.

AU - Boop, Frederick A.

AU - Merchant, Thomas E.

AU - Robinson, Giles W.

AU - Northcott, Paul A.

AU - Gajjar, Amar

PY - 2020/2/1

Y1 - 2020/2/1

N2 - The original version of this article unfortunately contained a typesetting error in Fig 3c. The corrected Fig. 3 is given in the following page (Figure presented.).

AB - The original version of this article unfortunately contained a typesetting error in Fig 3c. The corrected Fig. 3 is given in the following page (Figure presented.).

UR - http://www.scopus.com/inward/record.url?scp=85076888521&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85076888521&partnerID=8YFLogxK

U2 - 10.1007/s00401-019-02115-8

DO - 10.1007/s00401-019-02115-8

M3 - Comment/debate

C2 - 31865440

AN - SCOPUS:85076888521

SN - 0001-6322

VL - 139

SP - 273

EP - 275

JO - Acta Neuropathologica

JF - Acta Neuropathologica

IS - 2

ER -

Correction to: Risk-adapted therapy and biological heterogeneity in pineoblastoma: integrated clinico-pathological analysis from the prospective, multi-center SJMB03 and SJYC07 trials (Acta Neuropathologica, (2020), 139, 2, (259-271), 10.1007/s00401-019-02106-9)

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this